Damien Luque-Paz

25PUBLICATIONS
76CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursPredictive and prognostic markersRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 04, 2026
Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis.

|Dec 23, 2025
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Alexandre Guy, Olivier Mansier, Matisse Decilap

|Sep 08, 2025
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study.

Corentin Orvain, Suzanne Tavitian, Clémence Mediavilla

|Jun 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patients.

Olivier Mansier, Eric Lippert, Lina Benajiba

|Jan 17, 2025
Relationship between additional mutations at diagnosis and treatment response in patients with essential thrombocythemia.

Carole Mosnier, Sarah Bellal, Laurane Cottin

|Nov 19, 2024
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.

Damien Luque Paz, Nico Gagelmann, Lina Benajiba

Pageof 5

Frequent Collaborators

9 joint publications

Corentin Orvain

8 joint publications

Eric Lippert

7 joint publications

Jean-Christophe Ianotto

6 joint publications

Jérémie Riou